Search

Your search keyword '"Dufrost V"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Dufrost V" Remove constraint Author: "Dufrost V"
89 results on '"Dufrost V"'

Search Results

5. Facteurs précipitants la survenue d’un syndrome catastrophique des antiphospholipides : étude du rôle du traitement anticoagulant

6. Atteintes cutanées au cours du syndrome catastrophique des antiphospholipides – Cohorte descriptive multicentrique de 65 patients

9. Syndrome des antiphospholipides après 65 ans : étude comparative rétrospective des caractéristiques clinicobiologiques et des récidives thrombotiques

14. Atteintes cutanées au cours du syndrome catastrophique des antiphospholipides : série de 65 patients

18. Augmentation du risque thrombotique chez les patients SAPL traités par anticoagulants oraux directs : résultats d’une méta-analyse internationale sur données individuelles

19. Epidemiology, natural history, diagnosis, and management of ovarian vein thrombosis: a scoping review.

20. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.

21. Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.

22. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.

23. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

24. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies.

25. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.

26. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses.

27. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

28. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

29. A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance.

30. Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.

31. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

32. A Giant Abdominal Aortic Aneurysm Revealing a Marfan Syndrome With a New FBN1 Mutation.

33. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.

34. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?

37. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.

38. Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study.

40. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

41. New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis.

42. Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future Perspectives.

45. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

46. Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study.

48. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.

50. Unexpected Cause of Bleeding.

Catalog

Books, media, physical & digital resources